Get the app Watchlists Portfolios Alerts Sign in Get started

Menu

Braveheart Bio, Inc. BRVE

Full chart Compare

Set alert

18.02 USD +0.61 (+3.47%)

Nov 6, 2026, 11:30 AM EST

17.09 Day range 18.10

16.70 52-week range 32.00

YTD: -39.53%
1 year: -39.53%

Funds holding BRVE, by value held
Fund	Value held	Weight in fund
FSPHX	$20.92M	0.31%
FGCKX	$15.75M	0.02%
VTI	$14.49M	0.00%
FIDGX	$11.87M	0.13%
FBIOX	$11.30M	0.19%
FHCIX	$10.10M	0.30%
FBTTX	$7.06M	0.30%
VXF	$5.08M	0.01%
FDSSX	$3.56M	0.03%
FDSCX	$2.91M	0.04%
SHSSX	$2.36M	0.04%
SCHA	$2.33M	0.01%
FSMAX	$2.09M	0.01%
BDMIX	$1.53M	0.01%
FTASX	$1.23M	0.01%
FFTMX	$1.19M	0.01%
FEYTX	$1.18M	0.02%
FSMO	$1.16M	0.08%
FSKAX	$910.29K	0.00%
FNCMX	$697.04K	0.00%

Held by insiders 58.16%

Held by institutions 31.06%

Float held by institutions 74.24%

Institutions 20

Top institutional holders
Holder	% held	Shares	Value	Reported
Leonard Rickey Investment Advisors P.L.L.C.	0.04%	36,109	628.84K	Sep 29, 2026
SBI Securities Co., Ltd.	0.00%	10	174	Sep 29, 2026
Citigroup Inc.	0.00%	919	16.00K	Sep 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
SmallCap World Fund Inc	2.52%	2,273,151	39.59M	Sep 29, 2026
Fidelity Select Portfolios-Select Health Care Portfolio	1.15%	1,035,862	18.04M	Sep 29, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund	0.87%	779,600	13.58M	Sep 29, 2026
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total	0.67%	600,000	10.45M	Aug 30, 2026
Fidelity Select Portfolios-Select Biotechnology Portfolio	0.62%	559,564	9.74M	Sep 29, 2026
Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund	0.56%	500,000	8.71M	Sep 29, 2026

BRVE insiders
Insider	Relation	Latest transaction	Date	Shares held
CHIMOVITS EREZ	Director and Beneficial Owner of more than 10% of a Class of Security	Purchase	Aug 6, 2026	0
JIANGSU HENGRUI PHARMACEUTICALS CO. LTD.	Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	Aug 6, 2026	7,420,090
LUBNER DAVID CHARLES	Director	Purchase	Aug 6, 2026	55,555
MURDOCH TRAVIS	Chief Executive Officer	Purchase	Aug 6, 2026	8,333,640
RICKEY JAMES PAUL	Chief Financial Officer	Purchase	Aug 6, 2026	703,575
VIEHBACHER CHRISTOPHER	Director	Purchase	Aug 6, 2026	759,857